<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Das, Arup</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Novel Pharmacotherapies in the Treatment of Diabetic Retinopathy</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">33-34</style></pages><abstract><style  face="normal" font="default" size="100%">This article provides an overview of emerging pharmacotherapies for the treatment of diabetic retinopathy (DR). Specific topics include laser treatment, the targeting of vascular endothelial growth factor, steroid therapy, and other current approaches for DR therapy.</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>